Woman Man
- | Country :
- Serbia
- | organs : -
- | Specialty : -
Extract
This is a Phase II study designed to evaluate whether the co-administration of a fixed dose of tesmilifene and a standard regimen of docetaxel alters the plasma pharmacokinetics of docetaxel. This study will also assess the safety and efficacy of the tesmilifene/docetaxel combination in metastatic breast cancer patients.
Inclusion criteria
- Metastatic breast cancer